SCHEMBL4440700

SCHEMBL4440700

COC(=O)CNC(=O)c1cc(Cl)c(Oc2ccc(N)cc2)c(Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.51
GAA P10253 3/20 0.51
ALDH1A1 P00352 2/20 0.46
MAPK1 P28482 1/20 0.45
TAS1R3 Q7RTX0 1/20 0.43
TAS1R1 Q7RTX1 1/20 0.43
TAS1R2 Q8TE23 1/20 0.43
KMT2A Q03164 3/20 0.42
PKM P14618 1/20 0.42
MAPT P10636 2/20 0.41
HIF1A Q16665 1/20 0.41
SLC22A6 Q4U2R8 1/20 0.41
SLC22A8 Q8TCC7 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MEN1 O00255 2/20 0.41
HSD17B10 Q99714 2/20 0.41
TSHR P16473 1/20 0.41
MMP1 P03956 1/20 0.40
EPHX2 P34913 1/20 0.39
NR1H4 Q96RI1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3137803 0.85 KDM4E (0.51) KDM4EGAAALDH1A1MAPK1KMT2A
SCHEMBL3914958 0.83 GAA (0.53) KDM4EGAAALDH1A1KMT2APKM
SCHEMBL14392218 0.81 KDM4E (0.47) KDM4EGAAALDH1A1MAPK1KMT2A
SCHEMBL27474652 0.80 GAA (0.59) KDM4EGAAALDH1A1MAPK1KMT2A
SCHEMBL5279235 0.79 THRA (0.66) THRATHRB
SCHEMBL3923780 0.79 THRA (0.55) GAAALDH1A1THRATHRB
SCHEMBL5284091 0.78 RORC (0.60) KDM4EGAAKMT2APKMTHRA
SCHEMBL10528940 0.78 KDM4E (0.66) KDM4EGAAALDH1A1MAPK1KMT2A
SCHEMBL5280396 0.78 KDM4E (0.46) KDM4EGAAALDH1A1MAPK1TAS1R3
SCHEMBL3911709 0.77 THRB (0.48) ALDH1A1KMT2AMAPTHSD17B10THRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090318514-A1 Novel Pharmaceutical Compositions KARO BIO AB (SE) 2009-12-24 US disclosed
US-20090318514-A1 Novel Pharmaceutical Compositions KARO BIO AB (SE) 2009-12-24 US disclosed
US-20090318514-A1 Novel Pharmaceutical Compositions KARO BIO AB (SE) 2009-12-24 US disclosed
WO-2007128492-A1 NOVEL PHARMACEUTICAL COMPOSITIONS KARO BIO AB (SE) 2007-11-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318514-A1 Novel Pharmaceutical Compositions TSHR, TRHR, THRA KDM4E 1775/4885GAA 3977/4885ALDH1A1 1459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.